1. Volume 63, Issue 1, Pages 145-154 (January 2013)
Comparative Outcomes of Primary, Recurrent, and Progressive High-risk Non–muscle- invasive Bladder Cancer 
Francis Thomas, Aidan P. Noon, Naomi Rubin, John R. Goepel, James W.F. Catto 
European Urology 
Volume 63, Issue 1, Pages (January 2013)
DOI: /j.eururo
Copyright © Terms and Conditions

2. Fig. 1
The grouping and exclusion strategy for tumours within this study. MIBC=muscle-invasive bladder cancer; RHH=Royal Hallamshire Hospital; UCC=urothelial cell carcinoma.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions

3. Fig. 2
The natural history of primary, progressive, and recurrent high-risk non–muscle-invasive bladder tumours. MIBC=muscle-invasive bladder cancer; DSM=disease-specific mortality.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions

4. Fig. 3
Progression-free, disease-specific, and other-cause specific survival stratified by tumour grouping in (a) all patients, (b) those with no invasion (pTa and pTis), and (c) those with lamina propria invasion (pT1). Data were plotted using the Kaplan-Meier method. DSM=disease-specific mortality; OCM=other-cause mortality.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions